FMOC-Ser(tBu)-Bt

CAS No. 1126433-40-6

FMOC-Ser(tBu)-Bt

2-Butenedioic acid, 2-[2-(acetyloxy)-3,4,5,6-tetrachlorophenyl]-, diethylester, (E)- 137676-12-1

1H-Benzimidazol-2-amine,1-(phenylmethyl)-N-4-piperidinyl-5-(trifluoromethyl)-, dihydrobromide 75970-66-0

Carbamic acid,[9-[2-[10-[(methoxycarbonyl)amino]decylidene]-4-oxo-3-oxetanyl]nonyl]-,methyl ester 105251-86-3

2,3-Quinoxalinedione,7-[[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]-1-piperazinyl]methyl]-1,4-dihydro-1-methyl- 874277-48-2

Cyclohexaneacetamide, N-heptyl-N-(5-hydroxypentyl)- 139772-97-7

2(1H)-Quinoxalinone,6-[[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]-1-piperazinyl]methyl]-3,4-dihydro-3-(phenylmethyl)-, (3R)- 874277-85-7

2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-, 1-oxide 835621-12-0

Polyphenyls, biphenyl-free 68514-81-8

D-Valine, N-[N-[N-[N-[N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-tyrosyl]-3-[[( 4-methylphenyl)methyl]thio]-D-valyl]glycyl]-L-phenylalanyl]-3-[[(4-methylph enyl)methyl]thio]- 137684-71-0

7-cyano-4-chromanol 1376706-69-2

2,3-Quinoxalinedione,6-[[(2R)-4-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-4-yl]-2-methyl-1-piperazinyl]methyl]-1,4-dihydro- 874277-42-6

Butanedioic acid, heptylidene-, 1-ethyl ester, (E)- 137669-43-3

{4-[5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-2-oxobutylidene}diazenium (non-preferred name) 75863-53-5

1,3-Butanedione, 1-[7-(diethylamino)-2-oxo-2H-1-benzopyran-3-yl]- 137728-19-9

1,3,4-Thiadiazole,2-(3-azidopropyl)-5-(2,5-difluorophenyl)-3-(2,2-dimethyl-1-oxopropyl)-2,3-dihydro-2-phenyl- 885065-16-7

Benzenemethanol, a-methyl-a-octyl-, (R)- 137628-37-6

Phosphonium, [2-[4-(hexyloxy)phenyl]ethyl]triphenyl-, bromide 104948-04-1

2(1H)-Quinoxalinone,6-[[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]-1-piperazinyl]methyl]-3,4-dihydro-3-(2-methylpropyl)-, (3R)- 874277-92-6

1,3,4-Oxadiazole-3(2H)-carboxamide,2-[3-(4-cyclohepten-1-ylamino)propyl]-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl- 885065-11-2

2,4-Imidazolidinedione,1-[2-[[4-benzo[b]thien-2-yl-5-(3-pyridinyl)-2-pyrimidinyl]amino]ethyl]-5,5-dimethyl- 893435-29-5

Benzene, mono-C12-14-alkyl derivs., fractionation bottoms 68515-32-2

2(3H)-Furanone, dihydro-4-pentylidene-, (E)- 137669-52-4

1,2,5-Heptatriene, (Z)- 137670-04-3

2(3H)-Furanone, 4-heptyldihydro- 137669-60-4

2H-Indol-2-one,5-bromo-3-[(4-chlorophenyl)imino]-1,3-dihydro-1-methyl- 758718-37-5

2,3-Quinoxalinedione,6-[[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]-1-piperazinyl]methyl]-1,4-dihydro-1-(2-phenylethyl)- 874277-76-6

Benzenesulfonamide,3-[2-methoxy-6-[[2-(4-methoxyphenyl)ethyl]amino]-4-pyrimidinyl]- 885066-05-7

Benzeneacetic acid, 2-methyl-1-cyclohexen-1-yl ester 137668-72-5

Cyclohexaneacetamide, N-(5-bromopentyl)-N-heptyl- 139772-98-8

7-chloro-1,3,5-triazoniatricyclo[3.3.1.1~3,7~]decane 52100-95-5

Sodium;6-amino-5-carbamoyl-2-methylpyridine-3-carboxylate 137664-20-1

4-Pyrimidinamine, 6-chloro-2-methoxy-N-[2-(4-methoxyphenyl)ethyl]- 885066-04-6

2,3-Quinoxalinedione,6-[[(2S)-4-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-4-yl]-2-methyl-1-piperazinyl]methyl]-1,4-dihydro- 874277-43-7

1,2,5-Hexatriene, 4-methyl- 137670-03-2

Benzenesulfonamide, N-[4-(2-ethyl-2-hydroxybutyl)-2-thiazolyl]-3-fluoro- 892952-32-8

Piperazine, 2-(4-methylphenyl)-, (±)- 137684-20-9

Benzenesulfonamide,3-chloro-N-[4-(1-hydroxycyclopentyl)-2-thiazolyl]-2-methyl- 892947-11-4

2,3-Quinoxalinedione,1-cyclopentyl-7-[[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]-1-piperazinyl]methyl]-1,4-dihydro- 874277-54-0

Benzoic acid, 2-[(9H-xanthen-9-ylamino)carbonyl]- 105251-73-8

2(3H)-Furanone, 4-butylidenedihydro-, (E)- 137669-51-3

1-Pentyn-3-ol, 1-(1-cyclohexen-1-yl)-3-methyl-, (R)- 137628-47-8

2(1H)-Quinoxalinone,6-[[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]-1-piperazinyl]methyl]-3,4-dihydro-3-(1H-imidazol-4-ylmethyl)-, (3R)- 874277-86-8

2,3-Quinoxalinedione,6-[[(2S)-4-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-4-yl]-2-ethyl-1-piperazinyl]methyl]-1,4-dihydro- 874277-44-8

1,2,5-Heptatriene, (E)- 137670-05-4

2-(1,1-dimethylethoxy)acetic acid methyl ester 137676-99-4

2,5-Cyclohexadien-1-one,2,4-dimethoxy-3-methyl-5-(1-methylethoxy)-4-(2,4-pentadienyl)-, (E)- 105103-91-1

Polyphosphoric acids, polymers with tall oil and triethanolamine, potassium salts 68514-89-6

2H-1-Benzopyran-2-one,3-[1-(2,5-dichlorophenyl)-3-methyl-1H-pyrazol-5-yl]-7-(diethylamino)- 137728-14-4

Piperazine, 2-(1,3-benzodioxol-5-yl)-, (±)- 137684-56-1

2,3-Quinoxalinedione,6-[[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]-1-piperazinyl]methyl]-1,4-dihydro-1-(phenylmethyl)- 874277-73-3

9-Borabicyclo[3.3.1]nonane, 9-hydroxy-, lithium salt 137669-78-4

Benzene, mono-C9-11-alkyl derivs. 85117-39-1

1H-Indole-3-propanoic acid,5-methoxy-1-[[4-(3-pyridinylmethoxy)phenyl]sulfonyl]- 835620-57-0

Phosphoric acid, diethyl4-(2-methyl-1,3-dioxolan-2-yl)-1-cyclohexen-1-yl ester 137626-79-0

1H-Benzimidazole,2-[4-(1,1-dimethylethyl)phenyl]-4-[4-[(2-methoxy-4-pyrimidinyl)methyl]-1-piperazinyl]- 874277-06-2

2(3H)-Furanone, 4-hexylidenedihydro-, (E)- 137669-53-5

3-Quinolinecarboxaldehyde, 2,7-dichloro-6-fluoro- 137684-12-9

N,N-dipropyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amine 137731-05-6

ethyl 4-(4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-yl)piperazine-1-carboxylate 137731-15-8

2(1H)-Quinoxalinone,6-[[4-[2-(4-ethylphenyl)-1H-benzimidazol-4-yl]-1-piperazinyl]methyl]-3,4-dihydro-3-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3R)- 874277-87-9